Amalgamated Bank Ikena Oncology, Inc. Transaction History

Amalgamated Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$1.27 - $2.0 $1,445 - $2,276	-1,138 Reduced 61.35%	717 $1,000
Q4 2023 Feb 06, 2024	SELL	$1.33 - $4.4 $283 - $937	-213 Reduced 10.3%	1,855 $4,000
Q2 2023 Aug 11, 2023	BUY	$3.5 - $7.31 $7,238 - $15,117	2,068 New	2,068 $13,000
Q2 2022 Aug 15, 2022	SELL	$3.23 - $7.4 $11,146 - $25,537	-3,451 Closed	0 $0
Q1 2022 Jun 30, 2022	BUY	$5.61 - $13.85 $19,360 - $47,796	3,451 New	3,451 $21,000

30.6M

Ticker IKNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,257,500
Market Cap $55.5M
Description
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.